Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Treatment guidelines for patients with genotype 1 chronic hepatitis C infection].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti - 1 Oct 2013

Vince Adriana, Duvnjak Marko, Kurelac Ivan

Abstract excerpt

Dual therapy based on the combination of pegylated interferon-alpha 2a or 2b (PEG IFN-alpha2) and ribavirin has been considered standard-of-care treatment for chronic hepatitis C genotype 1 up to 2011. The first generation of protease inhibitors, boceprevir and telaprevir, have been approved for clinical use in Europe and USA since 2011. Therefore, national guidelines for the treatment of chronic hepatitis C...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Croatia
Share to Drug Therapy, Combination
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon alpha-2

Share to National Health Programs

Share to Polyethylene Glycols

Share to Practice Guidelines as Topic

Share to Ribavirin

Source

Identifiers

PMID: 24984333

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Treatment guidelines for patients with genotype 1 chronic hepatitis C infection].PMID 24984333Read ↗

[Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].Semantic proximity Read ↗

Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir.Semantic proximity Read ↗

[Hepatitis C: epidemiology, management and treatment].Semantic proximity Read ↗

Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver.Semantic proximity Read ↗

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases.Semantic proximity Read ↗

A review of standard and newer treatment strategies in hepatitis C.Semantic proximity Read ↗

JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2Semantic proximity Read ↗

[Hepatitis C].Semantic proximity Read ↗

[Recommendations for the treatment of chronic genotype 1 hepatitis C virus infection].Semantic proximity Read ↗

[Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 1].Semantic proximity Read ↗

Treatment of hepatitis C monoinfection in adults--Dutch national guidelines.Semantic proximity Read ↗

Hepatitis C therapy update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.